| JY231(JY231) Injection for the Treatment of R/R B-cell Malignancies (NCT07065279) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2025-07-01 |
| Safety and Preliminary Efficacy of Anti-CDH17 CAR-T Cell Therapy in Patients with CDH17-positive Advanced Solid Tumors (NCT06820424) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2025-03-01 |
| JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE) (NCT06675422) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2024-10-09 |
| Safety and Efficacy of Anti-BCMA-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM (NCT06515262) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2024-07-01 |
| JY231 (JY231) Injection for the Treatment of B-cell Acute Lymphoblastic Leukemia (B-ALL) (NCT06514768) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2024-06-20 |
| Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP) (NCT06352281) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2024-02-01 |
| C752 for Refractory/Relapsed B Cell Non-Hodgkin Lymphoma (NCT06210243) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2023-12-24 |
| Study to Evaluate the Safety and Preliminary Efficacy of CLL1 and CD38 Dual CAR-T in r/r AML (NCT06110208) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2023-10-10 |
| A Study of Novel Anti-CD19 CAR-T in Patients With r/r B-Cell Malignancies (NCT05932173) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2023-07-01 |
| A Study of RD14-01 in Patients With Advanced Solid Tumors (NCT05748938) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2023-02-08 |
| Safety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM (NCT05739188) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2023-02-07 |
| A Study of Universal CD19-Targeted UCAR-NK Cells Combined With HSCT for B Cell Hematologic Malignancies (NCT05654038) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2022-12-08 |
| Novel Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALL (NCT05639179) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2022-12-05 |
| A Study of Anti-CD7 CAR-T Cells in Pediatric and Young Adult Patients With Relapse and Refractory T-ALL/ T-LBL (NCT04860817) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2021-12-01 |
| CD19 Targeted Universal Chimeric Antigen Receptor T Cells Injection for CD19+ Refractory/Relapsed B-cell Malignancies (NCT05105867) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2021-09-29 |
| Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Myeloid Leukemia (NCT04923919) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2021-09-14 |
| UCAR-T for CD19+ Refractory/Relapsed B Hematologic Malignancies (NCT05015972) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2021-08-20 |
| CD19 and BCMA Targeted Fast Dual CAR-T for CD19+ Refractory/Relapsed B-NHL (NCT04877080) | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 2021-05-05 |